Global Brachytherapy Devices Market – Snapshot

The global brachytherapy devices market is driven by increase in incidence of cancer, high prevalence of cervical & lung cancer in developing regions, developed health care infrastructure, rise in demand for brachytherapy treatment, supportive government initiatives, and high acceptance of minimal invasive surgeries. However, higher reimbursement rates of other advanced radiation therapies, such as, IMRT and proton therapy and increase in demand for robotic prostatectomies are restraining the global brachytherapy devices market.

brachytherapy devices industry

The global brachytherapy devices market has been segmented based on product type, dose rate, indication, end-user, and region. On the basis of product type, the global market has been classified into brachytherapy afterloaders, brachytherapy applicators, and others. The brachytherapy applicators segment has been bifurcated into intracavitary applicators, interstitial applicators, and others. Based on dose rate, the global brachytherapy devices market has been classified into high dose rate brachytherapy, low dose rate brachytherapy, pulse dose rate brachytherapy, and others. In terms of indication, the global brachytherapy devices market has been categorized into prostate cancer, breast cancer, cervical cancer, skin cancer, and others. By end-user, the global market has been divided into hospitals, cancer treatment centers, and others. The global brachytherapy devices market has been studied across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, in terms of region.

The brachytherapy applicators segment is estimated to expand at a CAGR of 8.4% and account for the dominant share of the  brachytherapy devices market during the forecast period. This therapy plays a pivotal role in cancer care treatment as they are more efficient and are used for patient navigation through cancer care continuum. Rise in investment in research & development on cancer also paves the way for the increasing demand for the therapy. Cervical cancer, being the fourth common type of cancer in women, affects 500,000 women every year globally. It is the largest growing market for brachytherapy, followed by prostate cancer, breast cancer, skin cancer, and others. Hospitals are the major customers of brachytherapy products as they have better reimbursement plans and advanced technology systems, followed by cancer treatment centers, and others.

In 2017, North America dominated the global brachytherapy devices market, followed by Europe, and Asia Pacific. Increase in demand for high-quality treatment, popularity of brachytherapy devices, and technological advancements are the factors driving the brachytherapy devices market in these regions. Increase in health care expenditure, favorable reimbursement policies, rise in prevalence of cancer, and growth of geriatric population are anticipated to drive the brachytherapy devices market during the forecast period.  Asia Pacific is the next growing market for brachytherapy devices. Factors likely to boost the growth of the brachytherapy devices market in the region are increase in population, rise in disposable income, and expansion of internal radiation facility. The brachytherapy devices market in Latin America and Middle East & Africa is expected to be driven by rising cancer incidence, growing patient population, improving economic conditions, and investments made by the government.

Key players operating in the global brachytherapy devices market include Boston Scientific Corporation, C.R. Bard, Inc., CIVCO Medical Instruments Co. Inc., Cook Medical, Eckert & Ziegler, BEBIG, Elekta AB, Theragenics Corporation, Varian Medical Systems Inc., iCAD Inc., Theragenics Corporation, and CIVCO Medical Solutions. Growing population, increasing demand for brachytherapy, rising prevalence of cancer in developing countries, and technological advancements are expected to drive the global brachytherapy devices market during the forecast period. Recent mergers & acquisitions executed by the key players act as a growth booster for the global brachytherapy devices market.

Global Brachytherapy Devices Market: Overview

This report analyzes the current and future scenario of the global brachytherapy devices market for the period 2018-2026. Rise in incidence of cancer, high acceptance of minimally invasive procedures, increase in popularity of brachytherapy, and technological advancements are likely to be the major drivers of the global brachytherapy devices market during the forecast period.

The global brachytherapy devices market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on product, dose rate, indication, end-user, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the global brachytherapy devices market.

Global Brachytherapy Market: Key Segments

Based on product type, the global brachytherapy devices market has been segmented into brachytherapy afterloaders, brachytherapy applicators, and others. The segments have been analyzed based on available products used during the treatment of cancer, and cost-effectiveness. In terms of dose rate, the global brachytherapy devices market has been classified into high dose rate brachytherapy, low dose rate brachytherapy, and pulse dose rate brachytherapy. By indication, the global brachytherapy devices market has been divided into prostate cancer, breast cancer, cervical cancer, skin cancer, and others. Based on end-user, the global brachytherapy devices market has been categorized into hospitals, cancer treatment centers, and others. Market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year.

Global Brachytherapy Market: Regional Outlook

In terms of region, the global brachytherapy devices market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies mentioned in the Report

The report also profiles major players operating in the global brachytherapy devices market based on various attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Cook Medical, Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson and Company), Eckert & Ziegler, iCAD Inc., Elekta AB, Varian Medical Systems, Theragenics Corporation, and CIVCO Medical Solutions.

The global brachytherapy devices market has been segmented as below:

  • Global Brachytherapy Devices Market, by Product Type
    • Brachytherapy Afterloaders
    • Brachytherapy Applicators
      • Intracavitary Applicators
      • Interstitial Applicators
      • Others
    • Others
  • Global Brachytherapy Devices Market, by Dose Rate
    • High Dose Rate (HDR) Brachytherapy
    • Low Dose Rate (LDR) Brachytherapy
    • Pulse Dose Rate(PDR)Brachytherapy
  • Global Brachytherapy Devices Market, by Indication
    • Prostate Cancer
    • Breast Cancer
    • Cervical Cancer
    • Skin Cancer
    • Others
  • Global Brachytherapy Devices Market, by End-user
    • Hospitals
    • Cancer Treatment Centers
    • Others
  • Global Brachytherapy Devices Market, by Region
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • South Africa
      • GCC Countries
      • Rest of Middle East & Africa
.